Home

Paul Edward Kelly, Director: Relmada Therapeutics RLMD Buy · Filed 24/09/11

Trade details

Type
Insider buy
Amount
$64,750
Shares · price
25,000 sh · $2.59 a share
Held after
212,295 sh
Trade date
24/09/09
Filed
24/09/11
Days to filing
2 days

First buy since 2023

Insiders buying this week
4 insiders
Holding change
+13.3%

Relmada Therapeutics trades, last 26 weeks

What else happened in Relmada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

Paul Edward Kelly's recent trades

  • Paul Edward Kelly

    BuyRelmada Therapeutics

    $198K

    Filed 25/11/06

  • Paul Edward Kelly

    BuyRelmada Therapeutics

    $86K

    Filed 25/05/20

Paul Edward Kelly, Director — bought $64.8K of Relmada Therapeutics RLMD · 25,000 sh @ $2.59 | Whalegun